Pfizer Inc. (PFE): Price and Financial Metrics

Pfizer Inc. (PFE): $33.94

0.77 (+2.32%)

POWR Rating

Component Grades








PFE Price/Volume Stats

Current price $33.94 52-week high $54.93
Prev. close $33.17 52-week low $31.77
Day low $32.76 Volume 44,615,196
Day high $33.96 Avg. volume 24,666,723
50-day MA $35.09 Dividend yield 5.11%
200-day MA $39.87 Market Cap 191.62B

PFE Stock Price Chart Interactive Chart >


  • PFE scores best on the Value dimension, with a Value rank ahead of 96.03% of US stocks.
  • PFE's strongest trending metric is Growth; it's been moving down over the last 177 days.
  • PFE ranks lowest in Growth; there it ranks in the 1st percentile.

PFE Stock Summary

  • With a market capitalization of $184,566,418,343, PFIZER INC has a greater market value than 99.09% of US stocks.
  • PFIZER INC's stock had its IPO on January 1, 1986, making it an older stock than 93.16% of US equities in our set.
  • As for revenue growth, note that PFE's revenue has grown -22.93% over the past 12 months; that beats the revenue growth of merely 11.29% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to PFIZER INC, a group of peers worth examining would be NFLX, SAP, AMGN, CSCO, and BMY.
  • Visit PFE's SEC page to see the company's official filings. To visit the company's web site, go to

PFE Valuation Summary

  • In comparison to the median Healthcare stock, PFE's EV/EBIT ratio is 6.03% lower, now standing at 10.9.
  • PFE's EV/EBIT ratio has moved down 18.5 over the prior 243 months.

Below are key valuation metrics over time for PFE.

Stock Date P/S P/B P/E EV/EBIT
PFE 2023-09-22 2.4 1.9 8.6 10.9
PFE 2023-09-21 2.4 1.9 8.6 10.9
PFE 2023-09-20 2.4 1.9 8.8 11.1
PFE 2023-09-19 2.5 1.9 8.9 11.2
PFE 2023-09-18 2.4 1.9 8.8 11.1
PFE 2023-09-15 2.5 1.9 9.0 11.2

PFE Growth Metrics

    Its 4 year net cashflow from operations growth rate is now at -11.47%.
  • The 3 year revenue growth rate now stands at 71.5%.
  • Its 5 year cash and equivalents growth rate is now at -46.98%.
Over the past 49 months, PFE's revenue has gone up $46,303,000,000.

The table below shows PFE's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 99,676 26,599 29,771
2022-06-30 101,132 31,454 29,309
2022-03-31 92,367 34,583 24,966
2021-12-31 81,288 32,580 21,979
2021-09-30 63,600 32,291 19,180
2021-06-30 51,637 23,552 13,228

PFE's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • PFE has a Quality Grade of B, ranking ahead of 88% of graded US stocks.
  • PFE's asset turnover comes in at 0.312 -- ranking 146th of 682 Pharmaceutical Products stocks.
  • XBIT, NERV, and BLUE are the stocks whose asset turnover ratios are most correlated with PFE.

The table below shows PFE's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-04 0.312 0.704 0.149
2021-04-04 0.265 0.763 0.116
2020-12-31 0.247 0.793 0.099
2020-09-27 0.282 0.799 0.083
2020-06-28 0.288 0.799 0.181
2020-03-29 0.307 0.799 0.200

PFE Price Target

For more insight on analysts targets of PFE, see our PFE price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $46.03 Average Broker Recommendation 1.8 (Hold)

Pfizer Inc. (PFE) Company Bio

Pfizer Inc. is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products. Pfizer was founded under its original name, Charles Pfizer & Company, in 1849 in Brooklyn, New York by Charles Pfizer and Charles Erhart. The company operates research and development facilities in United States and the United Kingdom and employs over 78,000 individuals worldwide. Some of the company’s more recognizable brands include Advil, Celebrex, Chantix, Chapstick, Dimetapp, Lipitor, Robitussin, and Viagra. Albert Bourla serves as Pfizer’s Chairman of the Board and Chief Executive Officer and the company is headquartered in New York, New York.

PFE Latest News Stream

Event/Time News Detail
Loading, please wait...

PFE Latest Social Stream

Loading social stream, please wait...

View Full PFE Social Stream

Latest PFE News From Around the Web

Below are the latest news stories about PFIZER INC that investors may wish to consider to help them evaluate PFE as an investment opportunity.

3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street

BioNTech (NASDAQ: BNTX) has turned in a dismal performance so far this year. The average analysts' price target reflects an upside potential of 56%. Granted, not every analyst is all that bullish about BioNTech.

Yahoo | October 1, 2023

Could Viatris Stock Help You Become a Millionaire?

Viatris' broad portfolio gives the business lots of stability and plenty of opportunities -- but is there enough there for the stock to be a great long-term investment?

Yahoo | September 30, 2023

Moderna's Shares Could Take Off if These 2 Things Happen

Moderna (NASDAQ: MRNA) used to be a stock market star, climbing 1,700% from the start of 2020 through July of 2021. Investors liked that, and it clearly showed in the stock performance. After all, the vaccine is Moderna's only product right now, and demand for it has declined.

Yahoo | September 30, 2023

Unveiling Pfizer (PFE)'s Value: Is It Really Priced Right? A Comprehensive Guide

A deep dive into Pfizer's current market valuation, financial strength, and growth prospects

Yahoo | September 29, 2023

Why Pfizer and BioNTech Stocks Zoomed Higher Today

The fight against COVID-19 isn't over yet, and the two companies remain very much in the battle.

Yahoo | September 29, 2023

Read More 'PFE' Stories Here

PFE Price Returns

1-mo -5.14%
3-mo N/A
6-mo -16.51%
1-year -19.31%
3-year 10.10%
5-year -3.75%
YTD -31.68%
2022 -10.41%
2021 66.69%
2020 3.23%
2019 -6.91%
2018 24.82%

PFE Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full PFE Dividend History

Continue Researching PFE

Want to see what other sources are saying about Pfizer Inc's financials and stock price? Try the links below:

Pfizer Inc (PFE) Stock Price | Nasdaq
Pfizer Inc (PFE) Stock Quote, History and News - Yahoo Finance
Pfizer Inc (PFE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!